| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 551 | JP 3 | 98.81 |
| Emergency and Acute Care Studies | Lifetime | 189 | JP 2 | 98.70 |
| Cardiac Arrest and Resuscitation | Lifetime | 563 | JP 5 | 98.50 |
| Sepsis Diagnosis and Treatment | Lifetime | 388 | JP 11 | 98.30 |
| Trauma and Emergency Care Studies | Lifetime | 354 | JP 4 | 98.18 |
| Esophageal and GI Pathology | Lifetime | 666 | JP 58 | 97.88 |
| Chronic Disease Management Strategies | Lifetime | 438 | JP 2 | 97.24 |
| Medical Coding and Health Information | Lifetime | 47 | JP 1 | 96.28 |
| Spinal Hematomas and Complications | Lifetime | 103 | JP 20 | 96.21 |
| Hip and Femur Fractures | Lifetime | 632 | JP 8 | 96.77 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 720 | JP 4 | 96.73 |
| Mechanical Circulatory Support Devices | Lifetime | 871 | JP 18 | 96.89 |
| Appendicitis Diagnosis and Management | Lifetime | 646 | JP 8 | 94.98 |
| Neurosurgical Procedures and Complications | Lifetime | 551 | JP 42 | 95.49 |
| Clinical practice guidelines implementation | Lifetime | 651 | JP 3 | 94.01 |
| Dysphagia Assessment and Management | Lifetime | 752 | JP 49 | 94.60 |
| Frailty in Older Adults | Lifetime | 965 | JP 41 | 94.38 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 327 | JP 3 | 94.02 |
| Nosocomial Infections in ICU | Lifetime | 612 | JP 9 | 94.56 |
| Coronary Artery Anomalies | Lifetime | 877 | JP 73 | 93.17 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 280 | JP 21 | 89.37 |
| Abdominal vascular conditions and treatments | Lifetime | 871 | JP 74 | 87.96 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 889 | JP 92 | 89.39 |
| Abdominal Surgery and Complications | Lifetime | 884 | JP 10 | 87.82 |
| Pericarditis and Cardiac Tamponade | Lifetime | 730 | JP 21 | 86.18 |
| Otolaryngology and Infectious Diseases | Lifetime | 534 | JP 17 | 84.20 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 1 | JP 1 | 98.33 |
| Emergency and Acute Care Studies | 2021-2025 | 33 | JP 2 | 98.26 |
| Chronic Disease Management Strategies | 2021-2025 | 46 | JP 1 | 97.85 |
| Medical Coding and Health Information | 2021-2025 | 3 | JP 1 | 96.47 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 265 | JP 3 | 97.29 |
| Trauma and Emergency Care Studies | 2021-2025 | 115 | JP 2 | 97.07 |
| Clinical practice guidelines implementation | 2021-2025 | 45 | JP 1 | 95.29 |
| Cardiac Arrest and Resuscitation | 2021-2025 | 278 | JP 7 | 97.02 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 229 | JP 11 | 96.14 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 255 | JP 6 | 95.54 |
| Respiratory Support and Mechanisms | 2021-2025 | 335 | JP 4 | 96.13 |
| Cardiac Health and Mental Health | 2021-2025 | 167 | JP 3 | 94.48 |
| Hip and Femur Fractures | 2021-2025 | 204 | JP 6 | 94.68 |
| Geriatric Care and Nursing Homes | 2021-2025 | 247 | JP 6 | 94.25 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 705 | JP 16 | 91.81 |
| Pneumonia and Respiratory Infections | 2021-2025 | 575 | JP 6 | 90.63 |
| Tracheal and airway disorders | 2021-2025 | 666 | JP 28 | 89.40 |
| Frailty in Older Adults | 2021-2025 | 685 | JP 75 | 90.34 |
| Mechanical Circulatory Support Devices | 2021-2025 | 810 | JP 29 | 91.29 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 971 | JP 17 | 89.41 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 394 | JP 5 | 86.99 |
| Urinary Tract Infections Management | 2021-2025 | 401 | JP 16 | 85.96 |
| Heart Failure Treatment and Management | 2021-2025 | 994 | JP 82 | 89.17 |
| Neurosurgical Procedures and Complications | 2021-2025 | 354 | JP 5 | 86.12 |
| Enhanced Recovery After Surgery | 2021-2025 | 300 | JP 9 | 82.50 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 651 | JP 36 | 82.79 |
| Cancer Diagnosis and Treatment | 2021-2025 | 613 | JP 74 | 78.95 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 839 | JP 49 | 80.88 |
| Pelvic and Acetabular Injuries | 2021-2025 | 848 | JP 32 | 82.93 |
| Otolaryngology and Infectious Diseases | 2021-2025 | 76 | JP 4 | 80.33 |
| Nosocomial Infections in ICU | 2021-2025 | 484 | JP 24 | 78.00 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 757 | JP 17 | 78.82 |
| Coronary Artery Anomalies | 2021-2025 | 463 | JP 33 | 77.29 |
| Streptococcal Infections and Treatments | 2021-2025 | 855 | JP 39 | 75.54 |
| Pediatric Urology and Nephrology Studies | 2021-2025 | 975 | JP 35 | 76.46 |
| Hernia repair and management | 2021-2025 | 930 | JP 11 | 73.37 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 811 | JP 17 | 72.44 |
| Drug-Induced Adverse Reactions | 2021-2025 | 656 | JP 35 | 73.34 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 768 | JP 20 | 71.64 |
| Clinical Nutrition and Gastroenterology | 2021-2025 | 872 | JP 45 | 71.96 |
| Surgical site infection prevention | 2021-2025 | 698 | JP 31 | 66.88 |
| Healthcare Decision-Making and Restraints | 2021-2025 | 538 | JP 6 | 66.59 |
| Intestinal Malrotation and Obstruction Disorders | 2021-2025 | 889 | JP 67 | 52.80 |
| Neurological and metabolic disorders | 2021-2025 | 708 | JP 66 | 42.01 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 927 | JP 114 | 42.10 |
| Legionella and Acanthamoeba research | 2021-2025 | 753 | JP 17 | 36.67 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 912 | JP 50 | 29.99 |